Intercept Pharmaceuticals | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
Acadia Pharmaceuticals 0 4.12M 2024-09
Alnylam Pharmaceuticals USD 38.65M 325K 2025-03
Amarin USD 3K 3K 2024-12
Amgen USD 723M 24M 2025-03
Arrowhead Research USD 21.64M 7K 2025-03
AstraZeneca 429M 28M 2024-12
Biogen USD 60M 200K 2024-12
Bristol-Myers Squibb USD 494M 2M 2025-03
Eli Lilly USD 243.7M 19M 2025-03
Gilead Sciences USD 260M 12M 2025-03
GlaxoSmithKline 162M 11M 2025-03
Incyte USD 660K 241K 2025-03
Ionis Pharmaceuticals USD 19M 16.41M 2025-03
Moderna USD 1000K 5M 2025-03
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
PTC Therapeutics USD 43.35M 1.24M 2024-12
Regeneron Pharmaceuticals USD 8.7M 1.8M 2025-03
Sarepta Therapeutics USD 4.92M 86K 2024-09
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



Intercept Pharmaceuticals Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.